Search
Search Results
##search.searchResults.foundPlural##
-
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1599PDF: 978Suppl. Files: 495HTML: 304 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
2465PDF: 643HTML: 382 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2930PDF: 983HTML: 311 -
-
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
3494PDF: 1045HTML: 3181flowcytometric result of peripheral blood sample: 260 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2623PDF: 862HTML: 1756 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2910PDF: 1240HTML: 3324 -
Pseudo-differentiation syndrome
1538PDF: 731HTML: 10888Figure 1: peripheral blood showing myeloblasts with auer rods: 163Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 147Figure 3: CXR showing pulmonary infiltartes with consolidation: 169Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 154Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 150 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
3255PDF: 952HTML: 6624Untitled: 290Untitled: 246Untitled: 265Untitled: 270 -
RECENT ADVANCES IN THE 5Q- SYNDROME
3120PDF: 1933HTML: 3838Pellagatti Fig 1: 269Pellagatti Fig. 2: 256 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
2017PDF: 1100HTML: 257 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
1076PDF: 575HTML: 344 -
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
2137PDF: 1019HTML: 1785Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 223 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
2270PDF: 901HTML: 270 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1272PDF: 817HTML: 1542Figure 1: 258Figure 2: 264 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
858PDF: 951PDF Supp. Files: 112HTML: 265 -
Magnusiomyces capitatus Breakthrough Infection in Allogeneic Hematopoietic Cell Transplant Recipients Receiving Echinocandin Prophylaxis: Clinical Features, Management, and Review of the Literature
110PDF: 199Suppl. Files: 33Html: 117Html Suppl. Files: 94 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1308PDF: 804Html: 125 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2220PDF: 845HTML: 3276 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3727PDF: 1631HTML: 4527CoverLetter: 258Figure1: 273 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1923PDF: 975HTML: 1029Referring article: 802







